Nuvasive Inc (NUVA) Return on Equity ROE from the second quarter 2023 to second quarter 2022 and annually, average high and low, overall ranking from Jun 30 2023 to Jun 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Nuvasive Inc  (NASDAQ: NUVA)

Nuvasive Inc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Nuvasive Inc in the second quarter 2023?
Nuvasive Inc achieved a return on average equity (ROE) of 3.28 % in its second quarter 2023, this is above NUVA's average return on equity of 1.3%.
Nuvasive Inc shareholder's equity over the 12 months ending in its second quarter 2023 are valued at $867 million

ROE has advanced compared to 2.37% in the first quarter 2023, due to net income growth.

Within the Medical Equipment & Supplies industry 53 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2023 from 1523 to 2058.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Equity Change 7.98 % 7.61 % 9.27 % 0.96 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions 28 20 40 -20 -40
Return On Equity (TTM) 3.28 % 2.37 % 4.84 % -2.5 % -4.92 %
NUVA's Total Ranking # 2058 # 1523 # 1562 # 0 # 0
Equity (TTM) in Millions 893 874 869 832 827
Seq. Equity Change 2.16 % 0.55 % 4.42 % 0.67 % 1.8 %
Seq. Net Income Change - - - - -

Back to NUVA Management Effectiveness >> NUVA's 5 Years Annual ROE >> Compare NUVA ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 54
Sector # 160
Overall # 2058

Return On Equity Statistics
High Average Low
17.62 %
1.3 %
-15.14 %
(Jun 30 2011)   (Jun 30 2012)





NUVA Annual Return On Equity (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Equity in Millions 869 795 919 0 835
Y / Y Equity Change 9.27 % -13.46 % - - 4.93 %
Net Income in Millions 40 -64 -37 65 12
Y / Y Net Income Change - - - 422.75 % -84.64 %
Return On Equity 4.65 % -8.06 % -4.04 % - 1.5 %

Back to NUVA Management Effectiveness >> NUVA's 5 Years Annual ROE >> Compare NUVA ROE to its Competitors




Annual Roe Comment
In 2022 ROE improved to 4.65 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
NUVA's' Return on Equity at Yahoo Finance
NUVA's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for NUVA's Competitors
Subscribers only: Roe for Nuvasive Inc's Suppliers
Subscribers only: Return On Equity for NUVA's Customers




Companies with similar Return On Equity at Jun 30 2023, within Healthcare Sector ROE
Electromed Inc   8.89 %
Masimo Corp  8.86 %
Align Technology inc   8.72 %
Glucotrack Inc   8.71 %
Avantor Inc   8.70 %
Healthcare Services Group Inc   8.58 %
Horizon Therapeutics Public Limited Company  8.54 %
Labcorp Holdings Inc   8.46 %
Addus Homecare Corp  8.40 %
Incyte Corporation  8.24 %
Fonar Corporation  8.13 %
Revvity Inc  7.95 %
Merit Medical Systems Inc  7.78 %
Lifevantage Corp  7.73 %
Integra Lifesciences Holdings Corp  7.62 %
Viemed Healthcare Inc   7.42 %
Staar Surgical Co  7.34 %
Lftd Partners Inc   7.12 %
Merck and Co Inc   7.07 %
Medtronic Plc  7.03 %
Moderna Inc   6.62 %
Repligen Corp  6.51 %
Becton Dickinson And Company  6.51 %
Lantheus Holdings Inc   6.41 %
Privia Health Group Inc   5.64 %
Macrogenics Inc   5.46 %
Envista Holdings Corporation  5.18 %
Sensus Healthcare Inc   5.09 %
Boston Scientific Corporation  5.08 %
Integer Holdings Corporation  5.05 %

Date modified: 2026-09-12T06:12:52+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.